CTR9

RNA polymerase-associated protein CTR9 homolog · Q6PD62 · CTR9 on Sugi Atlas →

0 patent compounds predicted against CTR9, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CTR9 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas PHASE1/PHASE2RECRUITING
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor PHASE1/PHASE2NOT_YET_RECRUITING
Clinical and Laboratory Analysis of Familial Cancer nanCOMPLETED
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis nanRECRUITING
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus nanUNKNOWN
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Telomeres Length in Israeli Fibrotic ILD Patients nanENROLLING_BY_INVITATION
A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients nanCOMPLETED
Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR nanCOMPLETED
Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional Thrombocytopenia nanCOMPLETED
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
Telomere Disclosure and Impact on Psychological Distress and Health Behaviors nanCOMPLETED
Gene Modifiers of Cystic Fibrosis Lung Disease nanACTIVE_NOT_RECRUITING
International PPB/DICER1 Registry nanRECRUITING
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) nanCOMPLETED
A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS nanNOT_YET_RECRUITING
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
ASO Treatment for Syndromic Craniosynostoses nanNOT_YET_RECRUITING
Acquirement of Clinical and Genomic Data to Diagnose in Rare Inherited Cardiomyopathy nanRECRUITING
Study on the Biological Prediction Models of Radiation Pneumonitis nanUNKNOWN
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma nanACTIVE_NOT_RECRUITING
Whole Genome Sequencing in the Neonatal Intensive Care Unit nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Candidate Gene for Hyperferritinemia nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a CTR9 binder may also engage these)

ProteinNameSimilarity
Q62018 1.000 Q62018 →
Q4QR29 1.000 Q4QR29 →
Q6DEU9 0.999 Q6DEU9 →
Q5M7J9 0.988 Q5M7J9 →
Q86WT1 0.987 Q86WT1 →
O89079 0.987 O89079 →
Q6INU8 0.987 Q6INU8 →
Q8AVU9 0.987 Q8AVU9 →
A4IHR1 0.986 A4IHR1 →
COPE Coatomer subunit epsilon 0.986 landscape →
Q5ZIK9 0.986 Q5ZIK9 →
Q99J38 0.985 Q99J38 →
Q4QQS2 0.985 Q4QQS2 →
A7YE96 0.985 A7YE96 →
Q7Z4L5 0.985 Q7Z4L5 →
Q8N4P2 0.984 Q8N4P2 →
Q60445 0.983 Q60445 →
B2RYD6 0.983 B2RYD6 →
O64748 0.983 O64748 →
A2AKQ8 0.983 A2AKQ8 →
Q0HA38 0.982 Q0HA38 →
ANAPC7 Anaphase-promoting complex subunit 7 0.982 landscape →
Q5RFR8 0.982 Q5RFR8 →
A6N6J5 0.982 A6N6J5 →
Q28104 0.982 Q28104 →
Q6INS3 0.981 Q6INS3 →
A6H739 0.981 A6H739 →
Q6P3X3 0.981 Q6P3X3 →
Q9WVM3 0.981 Q9WVM3 →
Q9CY00 0.980 Q9CY00 →